共 246 条
[1]
Jones TH(2010)Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol. Metab. 21 496-503
[2]
Kelly DM(2013)Testosterone: a metabolic hormone in health and disease. J. Endocrinol. 217 R25-R45
[3]
Jones TH(1992)The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int. J. Obes. 16 991-997
[4]
Mårin P(2005)Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28 1636-1642
[5]
Holmäng S(2015)The emancipation of testosterone from niche hormone to multi-system player Asian J. Androl. 17 58-60
[6]
Jönsson L(2008)Testosterone for the aging male; current evidence and recommended practice. Clin. Interv. Aging 3 25-44
[7]
Sjöström L(2011)Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 Diabetes 34 1669-1675
[8]
Kvist H(2011)Cardiovascular risk during androgen deprivation therapy for prostate cancer. Br. Med. J. 342 d3105-3318
[9]
Holm G(2004)The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89 3313-906
[10]
Lindstedt G(2006)Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 154 899-612